List of Tables
Table 1. Global Targeted Therapy for Brain Cancer Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Belzutifan (Welireg)
Table 3. Key Players of Bevacizumab (Avastin)
Table 4. Key Players of Everolimus (Afinitor)
Table 5. Global Targeted Therapy for Brain Cancer Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global Targeted Therapy for Brain Cancer Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 7. Global Targeted Therapy for Brain Cancer Market Size by Region (2020-2025) & (US$ Million)
Table 8. Global Targeted Therapy for Brain Cancer Market Share by Region (2020-2025)
Table 9. Global Targeted Therapy for Brain Cancer Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 10. Global Targeted Therapy for Brain Cancer Market Share by Region (2026-2031)
Table 11. Targeted Therapy for Brain Cancer Market Trends
Table 12. Targeted Therapy for Brain Cancer Market Drivers
Table 13. Targeted Therapy for Brain Cancer Market Challenges
Table 14. Targeted Therapy for Brain Cancer Market Restraints
Table 15. Global Targeted Therapy for Brain Cancer Revenue by Players (2020-2025) & (US$ Million)
Table 16. Global Targeted Therapy for Brain Cancer Market Share by Players (2020-2025)
Table 17. Global Top Targeted Therapy for Brain Cancer Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Targeted Therapy for Brain Cancer as of 2024)
Table 18. Ranking of Global Top Targeted Therapy for Brain Cancer Companies by Revenue (US$ Million) in 2024
Table 19. Global 5 Largest Players Market Share by Targeted Therapy for Brain Cancer Revenue (CR5 and HHI) & (2020-2025)
Table 20. Global Key Players of Targeted Therapy for Brain Cancer, Headquarters and Area Served
Table 21. Global Key Players of Targeted Therapy for Brain Cancer, Product and Application
Table 22. Global Key Players of Targeted Therapy for Brain Cancer, Date of Enter into This Industry
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Targeted Therapy for Brain Cancer Market Size by Type (2020-2025) & (US$ Million)
Table 25. Global Targeted Therapy for Brain Cancer Revenue Market Share by Type (2020-2025)
Table 26. Global Targeted Therapy for Brain Cancer Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 27. Global Targeted Therapy for Brain Cancer Revenue Market Share by Type (2026-2031)
Table 28. Global Targeted Therapy for Brain Cancer Market Size by Application (2020-2025) & (US$ Million)
Table 29. Global Targeted Therapy for Brain Cancer Revenue Market Share by Application (2020-2025)
Table 30. Global Targeted Therapy for Brain Cancer Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 31. Global Targeted Therapy for Brain Cancer Revenue Market Share by Application (2026-2031)
Table 32. North America Targeted Therapy for Brain Cancer Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 33. North America Targeted Therapy for Brain Cancer Market Size by Country (2020-2025) & (US$ Million)
Table 34. North America Targeted Therapy for Brain Cancer Market Size by Country (2026-2031) & (US$ Million)
Table 35. Europe Targeted Therapy for Brain Cancer Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 36. Europe Targeted Therapy for Brain Cancer Market Size by Country (2020-2025) & (US$ Million)
Table 37. Europe Targeted Therapy for Brain Cancer Market Size by Country (2026-2031) & (US$ Million)
Table 38. Asia-Pacific Targeted Therapy for Brain Cancer Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 39. Asia-Pacific Targeted Therapy for Brain Cancer Market Size by Region (2020-2025) & (US$ Million)
Table 40. Asia-Pacific Targeted Therapy for Brain Cancer Market Size by Region (2026-2031) & (US$ Million)
Table 41. Latin America Targeted Therapy for Brain Cancer Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 42. Latin America Targeted Therapy for Brain Cancer Market Size by Country (2020-2025) & (US$ Million)
Table 43. Latin America Targeted Therapy for Brain Cancer Market Size by Country (2026-2031) & (US$ Million)
Table 44. Middle East & Africa Targeted Therapy for Brain Cancer Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 45. Middle East & Africa Targeted Therapy for Brain Cancer Market Size by Country (2020-2025) & (US$ Million)
Table 46. Middle East & Africa Targeted Therapy for Brain Cancer Market Size by Country (2026-2031) & (US$ Million)
Table 47. Merck & Co. Company Details
Table 48. Merck & Co. Business Overview
Table 49. Merck & Co. Targeted Therapy for Brain Cancer Product
Table 50. Merck & Co. Revenue in Targeted Therapy for Brain Cancer Business (2020-2025) & (US$ Million)
Table 51. Merck & Co. Recent Development
Table 52. Roche Company Details
Table 53. Roche Business Overview
Table 54. Roche Targeted Therapy for Brain Cancer Product
Table 55. Roche Revenue in Targeted Therapy for Brain Cancer Business (2020-2025) & (US$ Million)
Table 56. Roche Recent Development
Table 57. Novartis Company Details
Table 58. Novartis Business Overview
Table 59. Novartis Targeted Therapy for Brain Cancer Product
Table 60. Novartis Revenue in Targeted Therapy for Brain Cancer Business (2020-2025) & (US$ Million)
Table 61. Novartis Recent Development
Table 62. Research Programs/Design for This Report
Table 63. Key Data Information from Secondary Sources
Table 64. Key Data Information from Primary Sources
Table 65. Authors List of This Report
List of Figures
Figure 1. Targeted Therapy for Brain Cancer Picture
Figure 2. Global Targeted Therapy for Brain Cancer Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Targeted Therapy for Brain Cancer Market Share by Type: 2024 VS 2031
Figure 4. Belzutifan (Welireg) Features
Figure 5. Bevacizumab (Avastin) Features
Figure 6. Everolimus (Afinitor) Features
Figure 7. Global Targeted Therapy for Brain Cancer Market Size by Application (2020-2031) & (US$ Million)
Figure 8. Global Targeted Therapy for Brain Cancer Market Share by Application: 2024 VS 2031
Figure 9. Hospital Case Studies
Figure 10. Retail Pharmacy Case Studies
Figure 11. Other Case Studies
Figure 12. Targeted Therapy for Brain Cancer Report Years Considered
Figure 13. Global Targeted Therapy for Brain Cancer Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 14. Global Targeted Therapy for Brain Cancer Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 15. Global Targeted Therapy for Brain Cancer Market Share by Region: 2024 VS 2031
Figure 16. Global Targeted Therapy for Brain Cancer Market Share by Players in 2024
Figure 17. Global Top Targeted Therapy for Brain Cancer Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Targeted Therapy for Brain Cancer as of 2024)
Figure 18. The Top 10 and 5 Players Market Share by Targeted Therapy for Brain Cancer Revenue in 2024
Figure 19. North America Targeted Therapy for Brain Cancer Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 20. North America Targeted Therapy for Brain Cancer Market Share by Country (2020-2031)
Figure 21. United States Targeted Therapy for Brain Cancer Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. Canada Targeted Therapy for Brain Cancer Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Europe Targeted Therapy for Brain Cancer Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Europe Targeted Therapy for Brain Cancer Market Share by Country (2020-2031)
Figure 25. Germany Targeted Therapy for Brain Cancer Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. France Targeted Therapy for Brain Cancer Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. U.K. Targeted Therapy for Brain Cancer Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Italy Targeted Therapy for Brain Cancer Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Russia Targeted Therapy for Brain Cancer Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Nordic Countries Targeted Therapy for Brain Cancer Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Asia-Pacific Targeted Therapy for Brain Cancer Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Asia-Pacific Targeted Therapy for Brain Cancer Market Share by Region (2020-2031)
Figure 33. China Targeted Therapy for Brain Cancer Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Japan Targeted Therapy for Brain Cancer Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. South Korea Targeted Therapy for Brain Cancer Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Southeast Asia Targeted Therapy for Brain Cancer Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. India Targeted Therapy for Brain Cancer Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Australia Targeted Therapy for Brain Cancer Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Latin America Targeted Therapy for Brain Cancer Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Latin America Targeted Therapy for Brain Cancer Market Share by Country (2020-2031)
Figure 41. Mexico Targeted Therapy for Brain Cancer Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Brazil Targeted Therapy for Brain Cancer Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Middle East & Africa Targeted Therapy for Brain Cancer Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Middle East & Africa Targeted Therapy for Brain Cancer Market Share by Country (2020-2031)
Figure 45. Turkey Targeted Therapy for Brain Cancer Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Saudi Arabia Targeted Therapy for Brain Cancer Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. UAE Targeted Therapy for Brain Cancer Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. Merck & Co. Revenue Growth Rate in Targeted Therapy for Brain Cancer Business (2020-2025)
Figure 49. Roche Revenue Growth Rate in Targeted Therapy for Brain Cancer Business (2020-2025)
Figure 50. Novartis Revenue Growth Rate in Targeted Therapy for Brain Cancer Business (2020-2025)
Figure 51. Bottom-up and Top-down Approaches for This Report
Figure 52. Data Triangulation
Figure 53. Key Executives Interviewed
